SynCore Biotechnology Co.,Ltd announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 1.313 million compared to TWD 2.082 million a year ago. Operating loss was TWD 73.732 million compared to TWD 85.178 million a year ago. Net loss was TWD 71.565 million compared to TWD 84.532 million a year ago. Basic loss per share from continuing operations was TWD 0.65 compared to TWD 0.87 a year ago.